Your browser doesn't support javascript.
Beyond COVID-19-a paradigm shift in infection management?
Vehreschild, Maria J G T; Tacconelli, Evelina; Giske, Christian G; Peschel, Andreas.
  • Vehreschild MJGT; German Centre for Infection Research, Partner Site Bonn-Cologne, Germany; University of Cologne, Department I of Internal Medicine, Cologne, Germany; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, Frankfurt, Germany.
  • Tacconelli E; Infectious Diseases Unit, Department of Diagnostics and Public Health, Verona University Hospital, Verona, Italy; Cluster of Excellence EXC2124 "Controlling Microbes to Fight Infections", University of Tübingen, Tübingen 72076, Germany; German Centre for Infection Research, Partner Site Tübingen, Ge
  • Giske CG; Division of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Peschel A; Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany; Cluster of Excellence EXC2124 "Controlling Microbes to Fight Infections", University of Tübingen, Tübingen 72076, Germany; German Centre for Infection Research, Partner Site Tübingen, Germ
Lancet Infect Dis ; 21(5): e117, 2021 05.
Article in English | MEDLINE | ID: covidwho-846505
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S1473-3099(20)30789-1

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S1473-3099(20)30789-1